p.118 抽出テキスト

value of admission wall motion score in acute myocardial infarction. A cross sectional echocardiographic study of 345 patients. Br Heart J 1986; 56: 422–427. PMID: 3790378 226. Nishimura RA, Tajik AJ, Shub C, et al. Role of two-dimensional echocardiography in the prediction of in-hospital complications after acute myocardial infarction. J Am Coll Cardiol 1984; 4: 1080–1087. PMID: 6501716 227. Stein JH, Neumann A, Preston LM, et al. Improved risk stratification in unstable angina: identification of patients at low risk for in-hospital cardiac events by admission echocardiography. Clin Cardiol 1998; 21: 725–730. PMID: 9789692 228. Shah BN, Balaji G, Alhajiri A, et al. Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit: mortality and morbidity outcomes from a real-world setting. Circ Cardiovasc Imaging 2013; 6: 202–209. PMID: 23258477 229. Hofmann R, James SK, Jernberg T, et al. DETO2X–SWEDEHEART Investigators. Oxygen Therapy in Suspected Acute Myocardial Infarction. N Engl J Med 2017; 377: 1240–1249. PMID: 28844200 230. Sepehrvand N, James SK, Stub D, et al. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials. Heart 2018; 104: 1691–1698. PMID: 29599378 231. Hofmann R, Witt N, Lagerqvist B, et al. DETO2X-SWEDEHEART Investigators. Oxygen therapy in ST-elevation myocardial infarction. Eur Heart J 2018; 39: 2730–2739. PMID: 29912429 232. Jernberg T, Lindahl B, Alfredsson J, et al. Long-term effects of oxygen therapy on death or hospitalization for heart failure in patients with suspected acute myocardial infarction. Circulation 2018; 138: 2754–2762. PMID: 30767504 233. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2012 年度合同研究班報告).ST 上昇型急性心筋梗塞の診療に関するガイドライン(2013 年改訂版).http://www.j-circ.or.jp/ guideline/pdf/JCS2013_kimura_h.pdf 234. Webb DJ, Muirhead GJ, Wulff M, et al. Sildenafil citrate potentiates the hypotensive effects of nitric oxide donor drugs in male patients with stable angina. J Am Coll Cardiol 2000; 36: 25–31. PMID: 10898408 235. European Study of Prevention of Infarct with Molsidomine (ESPRIM) Group. The ESPRIM trial: short-term treatment of acute myocardial infarction with molsidomine. Lancet 1994; 344: 91–97. PMID: 7912393 236. Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994; 343: 1115–1122. PMID: 7910229 237. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669–685. PMID: 7661937 238. Every NR, Parsons LS, Hlatky M, et al. Myocardial Infarction Triage and Intervention Investigators. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996; 335: 1253–1260. PMID: 8857004 239. Freimark D, Matetzky S, Leor J, et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol 2002; 89: 381–385. PMID: 11835915 240. Barbash I, Freimark D, Gottlieb S, et al. Israeli working group on intensive cardiac care, Israel heart society. Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration. Cardiology 2002; 98: 141–147. PMID: 12417813 241. Fuster V, Dyken ML, Vokonas PS, et al. Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group. Circulation 1993; 87: 659–675. PMID: 8425313 242. Becker RC. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction. Arch Pathol Lab Med 1993; 117: 89–96. PMID: 8418769 243. Juul-Möller S, Edvardsson N, Jahnmatz B, et al. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. Lancet 1992; 340: 1421–1425. PMID: 1360557 244. Yasue H, Ogawa H, Tanaka H, et al. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) Investigators. Effects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Am J Cardiol 1999; 83: 1308–1313. PMID: 10235086 245. Chesebro JH, Clements IP, Fuster V, et al. A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency. N Engl J Med 1982; 307: 73–78. PMID: 7045659 246. Chan FK, Chung SC, Suen BY, et al. Preventing recurrent upper

gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967–973. PMID: 11274623 247. 日本消化器病学会.消化性潰瘍診療ガイドライン2015(改訂第2 版).南江堂 2015. 248. Lev EI, Kornowski R, Vaknin-Assa H, et al. Effect of clopidogrel pretreatment on angiographic and clinical outcomes in patients undergoing primary percutaneous coronary intervention for ST-elevation acute myocardial infarction. Am J Cardiol 2008; 101: 435–439. PMID: 18312753 249. Vlaar PJ, Svilaas T, Damman K, et al. Impact of pretreatment with clopidogrel on initial patency and outcome in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a systematic review. Circulation 2008; 118: 1828–1836. PMID: 18852370 250. Yusuf S, Zhao F, Mehta SR, et al. Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345: 494–502. PMID: 11519503 251. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13–20. PMID: 12517460 252. Zijlstra F, Hoorntje JC, de Boer MJ, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413–1419. PMID: 10547403 253. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997; 336: 1621–1628. PMID: 9173270 254. Nordmann AJ, Hengstler P, Harr T, et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Am J Med 2004; 116: 253–262. PMID: 14969654 255. Zhu MM, Feit A, Chadow H, et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 2001; 88: 297–301. PMID: 11472712 256. Cantor WJ, Fitchett D, Borgundvaag B, et al. TRANSFER-AMI Trial Investigators. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009; 360: 2705–2718. PMID: 19553646 257. Di Mario C, Dudek D, Piscione F, et al. CARESS-in-AMI Investigators. Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in- AMI): an open, prospective, randomised, multicentre trial. Lancet 2008; 371: 559–568. PMID: 18280326 258. Fernández-Avilés F, Alonso JJ, Peña G, et al. GRACIA-2 (Groupo de Análisis de Cardiopatía Isquémica Aguda) Investigators. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J 2007; 28: 949–960. PMID: 17244641 259. Armstrong PW. WEST Steering Committee. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J 2006; 27: 1530–1538. PMID: 16757491 260. Schömig A, Mehilli J, Antoniucci D, et al. Beyond 12 hours Reperfusion AlternatiVe Evaluation (BRAVE-2) Trial Investigators. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial. JAMA 2005; 293: 2865–2872. PMID: 15956631 261. Gierlotka M, Gasior M, Wilczek K, et al. Reperfusion by primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction within 12 to 24 hours of the onset of symptoms (from a prospective national observational study [PL-ACS]). Am J Cardiol 2011; 107: 501–508. PMID: 21195380 262. Hannan EL, Samadashvili Z, Walford G, et al. Culprit vessel percu-

taneous coronary intervention versus multivessel and staged percutaneous coronary intervention for ST-segment elevation myocardial